Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AIKI AIkido Pharma	$6.48 +15.9%	$5.44	$3.31 ▼ $11.48	$35.54M	0.93	79,326 shs	689,684 shs
CLYM Climb Bio	$2.38 +8.7%	$1.50	$1.05 ▼ $8.79	$161.28M	-0.11	778,093 shs	799,762 shs
DKDCA Data Knights Acquisition	$0.78 +1.3%	$0.53	$5.00 ▼ $13.51	$4.04M	0.18	39,705 shs	363,159 shs
LUNA Luna Innovations	$0.77 -9.4%	$0.88	$0.22 ▼ $2.69	$26.15M	2.01	152,283 shs	17,592 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AIKI AIkido Pharma	+16.55%	+1.25%	+26.07%	+40.87%	+306.27%
CLYM Climb Bio	0.00%	+25.26%	+60.81%	+101.69%	+237,999,900.00%
DKDCA Data Knights Acquisition	-1.07%	+21.47%	+45.80%	+90.76%	-32.74%
LUNA Luna Innovations	0.00%	0.00%	-23.00%	+54.00%	-68.18%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AIKI AIkido Pharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CLYM Climb Bio	3.4097 of 5 stars	3.7	0.0	0.0	0.0	3.2	2.5	1.3
DKDCA Data Knights Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LUNA Luna Innovations	0.1433 of 5 stars	0.0	2.0	0.0	0.0	0.6	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AIKI AIkido Pharma	0.00	N/A	N/A	N/A
CLYM Climb Bio	3.33	Buy	$9.00	278.15% Upside
DKDCA Data Knights Acquisition	0.00	N/A	N/A	N/A
LUNA Luna Innovations	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest AIKI, LUNA, DKDCA, and CLYM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	CLYM Climb Bio	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/15/2025	CLYM Climb Bio	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$9.00
6/6/2025	CLYM Climb Bio	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$10.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AIKI AIkido Pharma	N/A	N/A	N/A	N/A	$19.27 per share	N/A
CLYM Climb Bio	N/A	N/A	N/A	N/A	$2.74 per share	N/A
DKDCA Data Knights Acquisition	N/A	N/A	$0.01 per share	111.42	($1.82) per share	N/A
LUNA Luna Innovations	$116.61M	0.22	$0.25 per share	3.03	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AIKI AIkido Pharma	-$7.17M	-$3.88	N/A	N/A	N/A	N/A	-18.21%	-16.94%	N/A
CLYM Climb Bio	-$73.90M	-$0.70	N/A	N/A	N/A	N/A	-23.10%	-22.47%	11/11/2025 (Estimated)
DKDCA Data Knights Acquisition	$340K	-$0.19	N/A	∞	N/A	N/A	N/A	-5.55%	N/A
LUNA Luna Innovations	$9.28M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest AIKI, LUNA, DKDCA, and CLYM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/12/2025	Q2 2025	CLYM Climb Bio	-$0.19	-$0.13	+$0.06	-$0.13	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AIKI AIkido Pharma	N/A	N/A	N/A	N/A	N/A
CLYM Climb Bio	N/A	N/A	N/A	N/A	N/A
DKDCA Data Knights Acquisition	N/A	N/A	N/A	N/A	N/A
LUNA Luna Innovations	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AIKI AIkido Pharma	N/A	29.54	29.54
CLYM Climb Bio	N/A	14.08	14.08
DKDCA Data Knights Acquisition	N/A	N/A	N/A
LUNA Luna Innovations	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AIKI AIkido Pharma	10.88%
CLYM Climb Bio	69.76%
DKDCA Data Knights Acquisition	35.35%
LUNA Luna Innovations	87.46%

Insider Ownership

Company	Insider Ownership
AIKI AIkido Pharma	8.60%
CLYM Climb Bio	0.80%
DKDCA Data Knights Acquisition	45.72%
LUNA Luna Innovations	7.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AIKI AIkido Pharma	4	5.49 million	5.01 million	Not Optionable
CLYM Climb Bio	9	67.76 million	67.22 million	N/A
DKDCA Data Knights Acquisition	2	5.17 million	2.81 million	Not Optionable
LUNA Luna Innovations	390	33.96 million	31.38 million	Optionable

AIKI, LUNA, DKDCA, and CLYM Headlines

Recent News About These Companies

Video captures personality of rescue dog Luna - the RSPCA’s longest staying resident

July 21, 2025 | msn.com

Notable Latino Leaders: Jose Luna

July 21, 2025 | biztimes.comB

LA County Sheriff Luna Defends Compliance with Federal Warrants

July 20, 2025 | davisvanguard.orgD

Florida Rep. Luna Demands DOJ Probe Into Fed Chair Powell Over “Crazy” $2.5 Renovation

July 19, 2025 | msn.com

Training facility blast caused ‘largest loss of life' for LASD, Sheriff Luna says

July 19, 2025 | msn.com

Explosion is LASD’s deadliest day in nearly 170 years, Luna says

July 19, 2025 | msn.com

KGB files on JFK to be released this fall: Rep. Anna Paulina Luna

July 18, 2025 | msn.com

KGB files on JFK assassination to be released in months: Luna

July 18, 2025 | msn.com

Rep. Luna's Update on JFK Files: Lone Gunman Theory Destroyed by Witness at Hospital - Rogue CIA Factions Also at Work

July 18, 2025 | msn.com

LASD transferred at least 20 inmates over to ICE. Sheriff Luna explains why

July 18, 2025 | msn.com

Is Luna Really Dead on 'The Bold and the Beautiful'?

July 18, 2025 | aol.comA

LA County cannot hand over immigrant inmates' data despite DOJ threat, Luna says

July 18, 2025 | msn.com

DOJ wants data on non-citizen inmates in California, Luna calls it 'impossible'

July 18, 2025 | yahoo.com

Diego Luna To Star Opposite Taylor Kitsch In Kidnapping Thriller ‘Eleven Days’

July 16, 2025 | msn.com

The Bold And The Beautiful Spoilers: Is Luna Hiding An Identical Twin? Discover the New ‘Ronna’ Character’s Major Twist!

July 16, 2025 | celebratingthesoaps.comC

Universal Audio's Luna DAW updated with AI tools, including voice control and instrument detection

July 15, 2025 | msn.com

The Bold And The Beautiful Spoilers: Luna Might Not Be Dead After All

July 13, 2025 | celebratingthesoaps.comC

The Bold And The Beautiful Spoilers: Finn’s Heartbreak Over Luna’s Death And The Blame Game With Steffy

July 13, 2025 | celebratingthesoaps.comC

The Bold and the Beautiful What-to-Watch Moments, July 14: Luna's death brings grief and mourning

July 13, 2025 | soapcentral.comS

The Bold and the Beautiful Rewrites Luna’s Backstory– When Did Poppy Become The Villain?

July 13, 2025 | celebratingthesoaps.comC

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIKI, LUNA, DKDCA, and CLYM Company Descriptions

AIkido Pharma NASDAQ:AIKI

$6.48 +0.89 (+15.92%)

As of 08/22/2025

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Climb Bio NASDAQ:CLYM

$2.38 +0.19 (+8.68%)

As of 08/22/2025 04:00 PM Eastern

Climb Bio Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody which has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Climb Bio Inc., formerly known as Eliem Therapeutics Inc., is based in WELLESLEY, Mass.

Data Knights Acquisition NASDAQ:DKDCA

$0.78 +0.01 (+1.32%)

As of 08/22/2025

Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.

Luna Innovations NASDAQ:LUNA

$0.77 -0.08 (-9.41%)

As of 08/22/2025 03:53 PM Eastern

Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time